Association of vascular aging and insulin resistance with cardiovascular outcomes in China: PURE cohort study
Authors:
Open Access
- 17 March 2026
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (6) , 12806-12817
Abstract
Background: Although vascular aging and insulin resistance (IR) are recognized contributors to cardiovascular disease (CVD) pathophysiology, their independent and joint associations with CVD outcomes have not been fully clarified in large population-based cohorts. Evidence regarding their complementary rather than mediating roles remains limited. Methods: We used data from the Prospective Urban Rural Epidemiology (PURE) China study, a large prospective cohort comprising 47 931 individuals from 12 provinces across China. Vascular aging was assessed using estimated pulse wave velocity and categorized into supernormal (SVA), healthy (HVA), and early vascular aging (EVA) based on cohort percentiles. IR was evaluated using the triglyceride–glucose (TyG) index. The primary outcome was major CVD events (myocardial infarction, stroke, and heart failure). Cox frailty models with center-level random effects were used to estimate adjusted hazard ratios (aHRs). Results: A total of 40 513 participants with complete information were included in the current study. Over a median follow-up of 11.9 years (interquartile ranges 9.5–12.5), 3615 major CVD events, 829 CVD deaths, and 2344 all-cause deaths occurred. Compared with HVA, EVA was associated with substantially higher risks of major CVD events [aHR = 2.17, 95% confidence interval (CI): 1.99–2.35], CVD mortality (aHR = 4.07, 95% CI: 3.47–4.76), and all-cause mortality (aHR = 2.93, 95% CI: 2.65–3.23), while SVA showed consistently lower risks. Furthermore, higher TyG index levels were independently associated with major CVD event risk in a dose-response manner. Exploratory analyses revealed no significant mediation by the TyG index or interaction between vascular aging and TyG levels. Joint analysis revealed that individuals with both EVA and high TyG had the greatest major CVD risk (aHR = 2.20, 95% CI: 1.75–2.77). Conclusions: EVA and IR were independently associated with higher CVD risk, highlighting the need for integrated vascular-metabolic risk assessment in clinical practice, although further validation is warranted.Keywords
This publication has 50 references indexed in Scilit:
- The Global Burden of Cardiovascular Diseases and RiskJACC, 2022
- Measuring and estimating insulin resistance in clinical and research settingsObesity, 2022
- The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseasesCurrent Opinion in Pharmacology, 2022
- Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysisTrends in Endocrinology & Metabolism, 2021
- Insulin resistance, cardiovascular stiffening and cardiovascular diseaseMetabolism, 2021
- Estimated pulse wave velocity and cardiovascular events in ChineseInternational Journal of Cardiology Hypertension, 2020
- Epigenetics and cardiovascular regenerative medicine in the elderlyInternational Journal of Cardiology, 2018
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial StiffnessJACC, 2010
- The Prospective Urban Rural Epidemiology (PURE) study: Examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countriesAmerican Heart Journal, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007